Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
200 MA @ $7.77 could bounce off it
200 MA @~$19
offering? what price?
is this done?
potential multi day runner here...
Correct
Trading OTC as of today
Delisted…
looking like time to buy here...
thanks for the update
sweet move here
looking for a retest of high .30's
why the drop today, cant find news.
dead cat bounce?
.30+ coming here...
whats moving this today?
looking good here, any news?
offering....
Galexxy’s Wellbeing Farms Develops International Export Business; Nominated for Leading Manufacturer Award
Newport Beach, CALIFORNIA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Galexxy Holdings Inc., (“Galexxy,” “GXXY”) (OTC: GXXY) is pleased to announce that its 100% owned subsidiary, Wellbeing Farms LLC, (“WellBeing,” “WBF”) is expanding its marketing reach to the European and UK markets.
Wellbeing Farms has received a nomination for a Leading Manufacturer Award at the White Label World Expo Series in Germany to be held in October; and this week the Company is presenting its superfood Functional Mushroom - CBD products at the world's largest event for online sellers at the White Label World Expo in New York. The Company believes that initial interest is very strong. Wellbeing is also competing for Innovative Product of the Year award at the White Label World Expo in London, UK in late February 2023.
Michael Biagi, WBF’s CEO stated that “By opening our extensive range of specially formulated Functional Mushroom - CBD health supplements for white labelling to international markets, the Company is very pleased with the response thus far and is expecting significant new export opportunities.”
The Global functional mushroom market size was valued at USD 24.97 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.5% from 2022 to 2028. This can be credited to the rising adoption of these mushrooms as superfoods, owing to their potential of various health benefits. Functional mushrooms have a possibility for a variety of applications in pharmaceutical and healthcare products. Owing to this, we believe, their demand will be on the rise in the coming years. Also, increasing product application in the medicinal industry as a health supplement is further driving the market growth. Ref: *Grand View Research
Michael Biagi further stated that; “We believe we’re at the forefront of Functional Mushroom - CBD formulated products. We’re excited to combine these uniquely differentiated products to our exciting marketing plan in order to meet growing consumer demand for easier and more convenient access to specialty health supplements”.
ready for another pop here...
buy responsibly and wait...and take profits.
It is done, back up it goes!
double bottom @ 12...wild day here
thanks for the gifts!!
got me some tickets...5 min chart oversold.
this is holding very well, should move soon
expecting an eod push here...
scary quiet here...
good news will send this flying.
this hit .13s before the offering, if no news this is heading sub .10
9 million shares offering announced on 8/25
bought some on the dip, it should retest the HOD.
Up to $14,785,490 Common Stock, only dollar amount specified.
https://ih.advfn.com/stock-market/NASDAQ/american-virtual-cloud-t-AVCT/stock-news/88966450/prospectus-filed-pursuant-to-rule-424b5-424b5
offering....
sweet pop, lets go! $$$
They had a buyout offer @ $ 9.00 per share last year!
https://avctechnologies.com/2021/04/07/avc-technologies-announces-receipt-of-unsolicited-non-binding-acquisition-proposal-and-exploration-of-strategic-alternatives/
any news???
nice move here, could squeeze.
great numbers. Yesterday was the the 10th consecutive trading day closing at a minimum of $1, that should meet nasdaq listing requirement. things are lining up nicely here.
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a grace period of 180 calendar days, or until August 31, 2022, to regain compliance with Nasdaq Listing Rule 5550(a)(2). Compliance will be achieved automatically and without further action when the closing bid price of the Company’s stock is at or above $1.00 for a minimum of 10 consecutive business days at any time during the 180-day compliance period, in which case Nasdaq will notify the Company of its compliance and the matter will be closed.